Investigating how puberty affects brain development and health
Official title: A Longitudinal Investigation of the Endocrine and Neurobiologic Events Accompanying Puberty
Run by National Institutes of Health Clinical Center (CC) · NCT01434368 · Data updated 2026-11-12
This study is trying to see how puberty affects brain development and health in healthy kids aged 8 by looking at changes in their brain function over time.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 7 Years to 35 Years |
| Sex | All |
| Enrollment | 480 (estimated) |
| Sponsor | National Institutes of Health Clinical Center (CC) NIH |
| Locations | 1 site (Bethesda, Maryland) |
| Status | Recruiting |
| Started | November 23, 2011 |
| Registry record updated | October 29, 2026 |
| Trial ID | NCT01434368 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are healthy children aged 8 years with normal IQ and growth patterns.
✕Probably not a fit
Patients with significant neurological or cognitive disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to explore the endocrine and neurobiological changes that occur during puberty and their impact on normal brain development. By utilizing functional magnetic resonance imaging (fMRI), researchers will assess how hormonal changes influence brain function and the emergence of neuropsychiatric disorders. The study will involve healthy child volunteers aged 8 years, who will be monitored over time to understand the natural history of puberty and its effects on neurodevelopment. The findings could provide insights into the timing and nature of puberty-related changes in brain structure and function.
Why it matters
Potential benefit: If successful, this study could enhance our understanding of puberty's role in the development of neuropsychiatric disorders, potentially leading to better prevention and treatment strategies.
How similar studies have gone: While there have been studies on puberty and neurodevelopment, this specific longitudinal approach using fMRI to investigate these changes is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
* INCLUSION CRITERIA - SAMPLE 1: Child volunteers will qualify for inclusion if they meet the following criteria: * Good general health and normal IQ; A normal IQ will be determined by the scores on Test of Irregular Word Reading Efficiency (TIWRE) * Age 8 years; * Body Mass Index (kg/m\^2) between the 15th and 85th percentiles for age and sex according to the US Centers for Disease Control and Prevention 2000 growth charts; * A normal tempo of growth as determined by skeletal age within +/- 1.64 standard deviations of chronologic age according to the Greulich and Pyle radiographic atlas (i.e., no evidence for precocious puberty or abnormal delay of maturation); Research criteria for determining bone age will be performed by the collaborating pediatric endocrinologist. This criterion is required only for the initial entry into this study and is not one of the inclusion criteria for subsequent visits. * No history of significant neurologic or cognitive disorders. Examples include neonatal anoxic encephalopathy, seizure disorders, autism, and most learning disorders including attention deficit hyperactivity disorder; * Able to provide assent. Parents will provide consent. * Able to speak and read English. EXCLUSION CRITERIA - SAMPLE 1: Child volunteers will be excluded for the following reasons: * Presence of any medical condition that increases risk for MRI (e.g., pacemaker, metallic foreign body in eye or other body part, dental braces); * Presence or history of medical conditions known to affect cerebral anatomy; * Children who are not pre-pubertal as indicated by the presence of Tanner stage 2 development (i.e., areolar development in girls and testicular volume \> 3 cc in boys); * Individuals who have, or whose parent or guardians have, current substance abuse or a psychiatric disorder or any other condition which, in the opinion of the investigators, would impede the ability to give informed consent or possibly hinder completion of the study; presence of any psychiatric disorder in the subject, sibling, or other first-degree relative; * Subjects who regularly use prescription medications (the use of over-the-counter medications will be reviewed on a case-by-case basis.); * For females who have reached menarche: Pregnancy, lactation, or inability or unwillingness to undergo pregnancy testing (a urine pregnancy test will be performed prior to all MRI and X-ray procedures for girls who have had the onset of menses); * Current or past use of psychiatric medication; * I.Q. \< 70 (determined by the scores on Test of Irregular Word Reading Efficiency \[TIWRE\]). INCLUSION CRITERIA - SAMPLE 2: Child volunteers will qualify for inclusion if they meet the following criteria: * Good general health and normal IQ; A normal IQ will be determined by the scores on Test of Irregular Word Reading Efficiency (TIWRE) * Ages 12-13 years; * Body Mass Index (kg/m\^2) between the 15th and 85th percentiles for age and sex according to the US Centers for Disease Control and Prevention 2000 growth charts; * A normal tempo of growth as determined by skeletal age within +/- 1.64 standard deviations of chronologic age according to the Greulich and Pyle radiographic atlas (i.e., no evidence for precocious puberty or abnormal delay of maturation); Research criteria for determining bone age will be performed by the collaborating pediatric endocrinologist. This criterion is required only for the initial entry into this study and is not one of the inclusion criteria for subsequent visits. * No history of significant neurologic or cognitive disorders. Examples include neonatal anoxic encephalopathy, seizure disorders, autism, and most learning disorders including attention deficit hyperactivity disorder; * Able to provide assent. Parents will provide consent. * Able to speak and read English. EXCLUSION CRITERIA - SAMPLE 2: Child volunteers will be excluded for the following reasons: * Presence of any medical condition that increases risk for MRI (e.g., pacemaker, metallic foreign body in eye or other body part, dental braces); * Presence or history of medical conditions known to affect cerebral anatomy; * Individuals who have, or whose parent or guardians have, current substance abuse or a psychiatric disorder or any other condition which, in the opinion of the investigators, would impede the ability to give informed consent or possibly hinder completion of the study; presence of any psychiatric disorder in the subject, sibling, or other first-degree relative; * Subjects who regularly use prescription medications (the use of over-the-counter medications will be reviewed on a case-by-case basis.); * For females who have reached menarche: Pregnancy, lactation, or inability or unwillingness to undergo pregnancy testing (a urine pregnancy test will be performed prior to all MRI and X-ray procedures for girls who have had the onset of menses); * Current or past use of psychiatric medication; * I.Q. \< 70 (determined by the scores on Test of Irregular Word Reading Efficiency \[TIWRE\]). INCLUSION/EXCLUSION CRITERIA - SAMPLE 3: Inclusion and exclusion criteria for sample 3 will be identical as those for sample 2 with the exception that children between the ages of 8 and 17 will be included. INCLUSION/EXCLUSION CRITERIA - SAMPLE 4: Sample 4 participants will also be volunteering in Protocol #95-M-0150 "Neurobiological Investigation of Patients with Schizophrenia Spectrum Disorders and Their Siblings," and/or Protocol #81-M-0126, "The Evaluation of Women with Menstrually-Regulated Mood and Behavioral Disorders," in which they will also have signed consent and through which they will have been screened. INCLUSION CRITERIA - SAMPLE 4: * Ages of 25 to 35 years at the time of enrollment. * Each subject must have a level of understanding sufficient to agree to all required tests and examinations and sign an informed consent document. * No use of psychotropic substances in the last 3 months. * No psychiatric or severe chronic medical illness at the time of the study, and by history. * Able to speak and read English. EXCLUSION CRITERIA - SAMPLE 4: * Presence of impaired hearing. * Pregnant or currently breast feeding. (a urine pregnancy test will be performed prior to MRI procedures in women). * Presence of a history head trauma with loss of consciousness in the last year or any evidence of functional impairment due to and persisting after head trauma. * Previous eye surgery with a prosthetic implant. * Participants with tattoos will be excluded if the tattoos are in a location on the body (eyes, lips, etc.) that could interfere with fMRI scans or contain a heavy metal content. * Presence of any non-organic implant or any other device such as: cardiac pacemaker, insulin infusion pump, implanted drug infusion device, cochlear, otologic, or ear implant, transdermal medication patch (Nitro), any metallic implants or objects, body piercing(s), bone/joint pin, screw, nail, plate, wire sutures or surgical staples, shunt. * Presence of cerebral or other aneurysm clips. * Presence of shrapnel or other metal imbedded in the body (such as from war wounds or accidents). * Previous employment in metal fields or with machines that may have left any metallic fragments in or near the eyes. * History of a severe accident in the past that may possibly have left metal in the body. * Psychological contraindications for MRI (e.g., suffer from claustrophobia); * Less than an 8th grade education or an IQ below 70 as determined by the scores on Test of Irregular Word Reading Efficiency \[TIWRE\] . INCLUSION/EXCLUSION CRITERIA - SAMPLE 5: Inclusion and exclusion criteria for sample 5 will be identical as those for samples 1 and 2 (i.e., children will either be age 8-9 or between the ages of 12 and 13) with the exception that children with a tempo of growth that is considered abnormal as demonstrated by skeletal age greater than two standard deviations in advance of their chronologic age according to the Greulich and Pyle Radiographic Atlas will be included. These children will be matched for age, Tanner stage, race, ethnicity, and BMI with children currently enrolled in the longitudinal study. SAMPLE 6 Participants will have participated in this protocol as children in either Sample 1 or sample 2. INCLUSION CRITERIA: * Age 19 to 30 years at the time of re-enrollment. * Each subject must have a level of understanding sufficient to agree to all required tests and examinations and sign an informed consent document. * Normal physical exam, routine labs and absence of axis 1 psychiatric illnesses as confirmed by a Structured Diagnostic Interview for DSM-5 (SCID). * No current use of psychotropic substances. EXCLUSION CRITERIA: * Presence of any implant or medical condition that increases risk for MRI (e.g., pacemaker, metallic foreign body in eye or other body part, dental braces); * Presence or history of medical conditions known to affect cerebral anatomy; * Individuals who have current substance abuse or a psychiatric disorder or any other condition which, in the opinion of the investigators, would impede the ability to give informed consent or possibly hinder completion of the study; * Current use of psychiatric medication or presence of any psychiatric disorder; * For females: pregnancy, lactation, or inability or unwillingness to undergo pregnancy testing (a urine pregnancy test will be performed prior to all MRI procedures);
Where it's running
-
National Institutes of Health Clinical Center
Bethesda, Maryland, United States Recruiting
Study contacts
- Principal investigator: Peter J Schmidt, M.D. — National Institute of Mental Health (NIMH)
- Study coordinator: Peter J Schmidt, M.D.
- Email: peterschmidt@mail.nih.gov
- Phone: (301) 496-6120
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Customized brain stimulation to help mood in bipolar disorder
This study tests whether personalized, non-invasive brain stimulation with rTMS can help people with bipolar depression see if their mood shifts toward euthymia.
-
Biomarker-guided antidepressant choice to see if rTMS or ketamine works best for you
This study tests whether brain and behavior markers can help match people with major depression to either rTMS or ketamine to see which works better for them.
-
12-week ETAS® supplement for thinking, mood, sleep, and brain health in older adults
This 12-week test will see if taking 1500 mg ETAS® daily helps thinking, mood, sleep, and brain scan measures in healthy adults aged 60–80 with mild cognitive complaints.
-
Functional brain signal changes after ACL reconstruction with targeted neuromotor training
This project will test whether targeted neuromotor training after ACL reconstruction changes brain activity patterns in active adults aged 18–30.
-
Evaluating brain connectivity in patients with refractory constipation
This study is trying to see how brain activity in people with stubborn constipation can help predict if they will respond well to fluoxetine and other treatments.
-
Exploring how the brain processes visual information
This study is testing how different parts of the brain help us recognize objects and understand where things are in space by having healthy adults do visual tasks while their brain activity is monitored.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.